Table 2.
Obese with complication (OBc-G) patients.
Code | Age (years) | Sex | BMI at onset | BMI-SDS | Obeisty subgroup | Total cholesterol | HDL | LDL | TRG | Glycemia 0' | Glycemia 60' | Glycemia 120 | Glicated Hb | Total insulin | CRP | Ultrasensitive CRP | Hepatic steatosis | Metformin therapy | Other clinical infos |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4V | 14.7 | F | ND | ND | ND | 194 | 34 | ND | ND | 82 | 194 | 184 | 5.25 | 2797 | 0.61 | 6 | Si | No | |
59D | 11.3 | M | 28 | 2.89 | OBc-O-G | 188 | 31 | 115 | 219 | 108 | 105 | 129 | 5.52 | 221 | 0.23 | ND | No | No | Language and learning difficulties |
80D | 11.5 | F | 27.3 | 2.45 | OBc-O-G | 176 | 56 | 105 | 108 | 101 | 148 | 138 | ND | 1404 | 0.23 | 0.14 | No | No | |
84D | 14.1 | M | 30 | 2.59 | OBc-O-G | 134 | 38 | 85 | 103 | 88 | 204 | 148 | 5.02 | 338 | 0.23 | 1.42 | Yes | Yes | Macrogol therapy |
86D | 6.1 | F | 28 | 4.28 | OBc-SO-G | 161 | 44 | 103 | 162 | ND | ND | ND | 4.64 | ND | 0.23 | 0.7 | ND | No | |
106D | 15.2 | M | 28.6 | 2.23 | OBc-O-G | 109 | 39 | 68 | 59 | 92 | 165 | 133 | 5.4 | 576 | 0.23 | 1.42 | Yes | No | Hypertension |
109D | 13.8 | M | 28.4 | 2.42 | OBc-O-G | 159 | 41 | 105 | 106 | 91 | 161 | 133 | 6.12 | 643 | 0.23 | 1.39 | No | No | |
112D | 13.7 | M | 32.8 | 2.98 | OBc-O-G | 277 | 34 | 210 | 262 | 97 | 121 | 124 | 5.88 | 842 | 0.23 | 2.91 | Yes | No | |
117D | 16.4 | F | 42.8 | 3.63 | OBc-SO-G | 161 | 47 | 106 | 115 | 89 | 172 | 152 | 5.36 | 861 | 0.76 | 6.64 | No | No | |
118D | 13.9 | M | 29 | 2.49 | OBc-O-G | 160 | 50 | 91 | 93 | 88 | 192 | 172 | 5.79 | 1869 | 0.82 | 7.35 | ND | No | Hypertension |
119D | 16.9 | M | 30 | 2.23 | OBc-O-G | 170 | 45 | 99 | 171 | 82 | 232 | 150 | 4.83 | 1746 | 0.23 | 0.64 | Yes | No | |
126D | 19.0 | F | 36.6 | 3.05 | OBc-SO-G | 135 | 34 | 83 | 163 | 89 | 113 | 124 | 4.96 | 865 | 0.23 | 3.56 | No | No | Estro-progestinic therapy |
141D | 13.0 | M | 26.7 | 2.3 | OBc-O-G | 170 | 38 | 112 | 154 | 94 | 133 | 121 | 5.48 | 876 | 0.23 | 2.3 | Yes | No | |
153D | 14.3 | M | 42.6 | 3.68 | OBc-SO-G | 111 | 36 | 66 | 56 | 78 | 112 | 113 | 5.62 | 1117 | 0.93 | 8.72 | No | Glucophage | Hypertension therapy with amlodipin, GHD |
157D | 12.8 | M | 25.2 | 2.16 | OBc-O-G | 197 | 36 | 116 | 338 | 83 | 154 | 133 | 5.82 | 892 | 0.23 | 0.98 | ND | No | |
166D | 14.8 | F | 41.2 | 3.51 | OBc-SO-G | 158 | 31 | 115 | 167 | 96 | 172 | 154 | 5.11 | 1892 | 0.23 | 2.57 | No | No | Hypertension |
169D | 10.8 | F | 37.4 | 3.65 | OBc-SO-G | 170 | 40 | 114 | 81 | 100 | 175 | 141 | 5.38 | 849 | 0.6 | 6.51 | ND | No | |
174D | 17 | M | 38.3 | 3.34 | OBc-SO-G | 140 | 39 | 101 | 65 | 108 | 158 | 151 | 4.96 | 1085 | 0.85 | 7.39 | Yes | No | Hypertension |
176D | 18.0 | F | 41.4 | 3.56 | OBc-SO-G | 192 | 39 | 139 | 151 | 99 | 136 | 110 | 5.44 | 625 | 1.38 | 11.49 | ND | No | |
182D | 12.8 | M | 50.6 | 4.04 | OBc-SO-G | 175 | 34 | 122 | 120 | 93 | 112 | 127 | 5.21 | 168 | 0.62 | 6.24 | Yes | No | Moderate OSAS |
189D | 13.0 | M | 45.3 | 3.86 | OBc-SO-G | 148 | 33 | 79 | 229 | 90 | 151 | 140 | 5.25 | 1600 | 0.7 | 6.3 | Yes | No | Mild OSAS |
Patients and relevant clinical features: Sex (M:male, F:female), BMI and BMI-SDS at onset, TRG: triglycerids, Obesity group (OB-O-G: Obese in Simple obesity, OB-SO-G: Severe Obese in Simple obesity, OBc-O*G: Obese in obesity with complication, OBc-SO-G: Severe Obese in obesity with complication. CRP (C-reactive protein): mg/dL (< = 0.23:negative value).